V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10002705 | 10001775 | 1.55 | 45 | Palliative (P) | 2016-09-28 | 2016-09-28 | PEMBROLIZUMAB | 02 | N | 10443436 | PEMBROLIZUMAB |
| 10002706 | 10006258 | 1.86 | 109 | Palliative (P) | null | 2018-03-05 | PEMBROLIZUMAB | 2 | N | 10443444 | PEMBROLIZUMAB |
| 10002707 | 10001776 | 1.7 | 62.2 | Curative (C) | 2016-10-21 | 2016-10-21 | Trial Unspecified | Y | N | 10443458 | TRIAL |
| 10002708 | 10006259 | null | 67.9 | Palliative (P) | 2017-06-27 | 2017-06-28 | Carboplatin + Vinorelbine Oral | N | null | 10443473 | CARBOPLATIN + VINORELBINE |
| 10002709 | 10001777 | 1.7 | 60 | Palliative (P) | 2016-10-13 | 2016-10-17 | PEMBROLIZUMAB | 2 | N | 10443516 | PEMBROLIZUMAB |
| 10002710 | 10006260 | 1.82 | 57.6 | Curative (C) | 2018-07-06 | 2018-07-11 | Cisplatin + Vinorelbine (IV) | N | null | 10443536 | CISPLATIN + VINORELBINE |
| 10002711 | 10001778 | 1.62 | 55.6 | Palliative (P) | 2016-09-30 | 2016-10-25 | GEMCITABINE | N | N | 10443561 | GEMCITABINE |
| 10002712 | 10001779 | 1.61 | 95.1 | Palliative (P) | 2016-06-07 | 2016-06-07 | Carboplatin + Vinorelbine Oral | 02 | N | 10443575 | CARBOPLATIN + VINORELBINE |
| 10002713 | 10001780 | 1.48 | 48.45 | Palliative (P) | 2018-10-26 | 2018-11-11 | Carboplatin + Vinorelbine Oral | N | null | 10443654 | CARBOPLATIN + VINORELBINE |
| 10002714 | 10001781 | 1.51 | 65 | null | 2017-02-20 | 2017-03-01 | Trial Unspecified | N | N | 10443809 | TRIAL |
| 10002715 | 10006261 | 1.74 | 75.6 | Palliative (P) | null | 2016-07-10 | Gemcitabine weekly | N | N | 10443817 | GEMCITABINE |
| 10002716 | 10006261 | 1.62 | 61.4 | Palliative (P) | 2017-08-25 | 2017-09-13 | Cisplatin + Vinorelbine (IV) | 2 | N | 10443817 | CISPLATIN + VINORELBINE |
| 10002717 | 10006261 | null | 93.5 | Palliative (P) | 2017-07-02 | 2017-07-02 | Enzalutamide | 2 | N | 10443817 | ENZALUTAMIDE |
| 10002718 | 10006261 | 1.69 | 90.85 | Palliative (P) | 2019-01-04 | 2019-01-04 | Enzalutamide | N | N | 10443817 | ENZALUTAMIDE |
| 10002719 | 10006261 | 1.71 | null | Palliative (P) | 2014-01-23 | 2014-01-23 | GEMCITABINE | N | N | 10443817 | GEMCITABINE |
| 10002720 | 10001782 | 1.82 | 86.8 | Palliative (P) | 2018-09-13 | 2018-09-23 | CISPLATIN + VINORELBINE | N | N | 10443977 | CISPLATIN + VINORELBINE |
| 10002721 | 10006262 | 0 | 68.1 | Palliative (P) | 2016-07-24 | 2016-07-24 | Cisplatin + Vinorelbine (IV) | N | N | 10443985 | CISPLATIN + VINORELBINE |
| 10002722 | 10008009 | 1.7 | 68.2 | Disease modification (D) | 2014-05-10 | 2014-05-10 | CVP R | N | N | 10443990 | CVP R |
| 10002723 | 10001783 | 1.74 | 92.5 | Palliative (P) | 2018-12-09 | 2018-12-09 | Trial Unspecified | Y | N | 10444120 | TRIAL |
| 10002724 | 10001784 | 1.82 | 63.4 | Palliative (P) | 2017-05-05 | 2017-05-05 | PEMBROLIZUMAB | 02 | N | 10444189 | PEMBROLIZUMAB |
| 10002725 | 10001785 | 1.71 | 55.6 | Disease modification (D) | 2016-10-17 | 2016-10-19 | CVP R | N | N | 10444190 | CVP R |
| 10002726 | 10001786 | 1.68 | 69 | Neo-adjuvant (N) | 2016-12-12 | 2016-12-18 | ECX | N | N | 10444224 | ECX |
| 10002727 | 10001787 | 1.7 | null | Palliative (P) | 2016-04-29 | 2016-05-18 | Cisplatin + Pemetrexed | 2 | N | 10444231 | CISPLATIN + PEMETREXED |
| 10002728 | 10006263 | 1.73 | 79.8 | Palliative (P) | 2017-10-21 | 2017-10-27 | Carboplatin + Vinorelbine Oral | 2 | N | 10444271 | CARBOPLATIN + VINORELBINE |
| 10002729 | 10001788 | 1.7 | 93 | Adjuvant (A) | 2014-09-07 | 2014-10-02 | Cisplatin + Vinorelbine (IV) | N | N | 10444284 | CISPLATIN + VINORELBINE |
| 10002730 | 10001789 | 1.79 | 84 | Adjuvant (A) | 2018-12-25 | 2018-12-25 | Cisplatin + Vinorelbine (IV) | N | N | 10444296 | CISPLATIN + VINORELBINE |
| 10002731 | 10001789 | 1.62 | 85 | Palliative (P) | 2016-10-20 | 2016-10-24 | PEMBROLIZUMAB | N | N | 10444296 | PEMBROLIZUMAB |
| 10002732 | 10001790 | 1.88 | 74.4 | Disease modification (D) | 2015-07-01 | 2015-07-02 | R GCVP | 2 | N | 10444298 | CVP R |
| 10002733 | 10001790 | 1.77 | null | Palliative (P) | null | 2017-02-02 | CVP R | N | N | 10444298 | CVP R |
| 10002734 | 10001790 | 1.68 | 74.4 | Curative (C) | 2015-05-05 | 2015-05-11 | CVP R | null | N | 10444298 | CVP R |
| 10002735 | 10001791 | 1.6 | 72 | Curative (C) | 2016-03-11 | 2016-03-20 | CVP R | 02 | N | 10444398 | CVP R |
| 10002736 | 10001791 | 1.72 | null | Palliative (P) | 2014-06-29 | 2014-06-29 | ECX | N | N | 10444398 | ECX |
| 10002737 | 10001792 | 1.65 | 58 | Curative (C) | 2017-02-20 | 2017-02-27 | CISPLATIN + VINORELBINE | 2 | N | 10444479 | CISPLATIN + VINORELBINE |
| 10002738 | 10001793 | 1.88 | 0 | Adjuvant (A) | 2017-03-19 | 2017-03-26 | CISPLATIN + VINORELBINE | N | N | 10444538 | CISPLATIN + VINORELBINE |
| 10002739 | 10001794 | 1.53 | 63.8 | Palliative (P) | 2018-04-04 | 2018-04-04 | Enzalutamide | 2 | N | 10444630 | ENZALUTAMIDE |
| 10002740 | 10001794 | null | 49.5 | Curative (C) | 2018-01-04 | 2018-01-24 | CVP R | N | N | 10444630 | CVP R |
| 10002741 | 10001794 | 0 | 74.4 | Disease modification (D) | 2018-11-26 | 2018-11-26 | Hydroxycarbamide | N | N | 10444630 | HYDROXYCARBAMIDE |
| 10002742 | 10001794 | 1.82 | 0 | Palliative (P) | 2016-10-25 | 2016-11-13 | Cisplatin + Pemetrexed | N | null | 10444630 | CISPLATIN + PEMETREXED |
| 10002743 | 10001794 | 1.75 | 101 | Neo-adjuvant (N) | 2017-08-04 | 2017-09-01 | Trial Unspecified | Y | N | 10444630 | TRIAL |
| 10002744 | 10009215 | 1.76 | 105 | Not known (9) | 2014-09-10 | 2014-09-21 | EOX | N | N | 10444733 | EOX |
| 10002745 | 10009215 | null | 57 | Disease modification (D) | 2016-06-08 | 2016-06-15 | Rituximab | 2 | N | 10444733 | RITUXIMAB |
| 10002746 | 10001795 | 0 | 0 | Palliative (P) | 2018-05-15 | 2018-05-16 | Enzalutamide | 02 | N | 10444862 | ENZALUTAMIDE |
| 10002747 | 10001796 | 1.72 | 64.3 | Palliative (P) | 2015-08-27 | 2015-08-27 | Enzalutamide | N | N | 10444910 | ENZALUTAMIDE |
| 10002748 | 10001796 | 0 | 82 | Not known (9) | 2017-06-19 | 2017-06-19 | Cisplatin + Vinorelbine (PO) | 02 | N | 10444910 | CISPLATIN + VINORELBINE |
| 10002749 | 10001796 | 1.62 | 78.6 | null | 2017-03-19 | 2017-03-21 | ECX | N | N | 10444910 | ECX |
| 10002750 | 10001797 | 0 | 67.4 | null | 2018-06-01 | 2018-06-07 | CARBOPLATIN + VINORELBINE | 02 | N | 10445101 | CARBOPLATIN + VINORELBINE |
| 10002751 | 10001798 | 1.47 | 67 | Palliative (P) | 2016-12-20 | 2016-12-29 | EOX | N | Y | 10445112 | EOX |
| 10002752 | 10001799 | 1.83 | 78.7 | Palliative (P) | 2017-10-19 | 2017-10-20 | Cisplatin + Pemetrexed | 2 | N | 10445140 | CISPLATIN + PEMETREXED |
| 10002753 | 10001799 | 1.69 | null | Palliative (P) | 2017-05-08 | 2017-05-24 | Cisplatin + Pemetrexed | N | N | 10445140 | CISPLATIN + PEMETREXED |
| 10002754 | 10001800 | 1.68 | null | Palliative (P) | 2018-05-12 | 2018-05-12 | Enzalutamide | 02 | N | 10445433 | ENZALUTAMIDE |